Long-term oxygen therapy shows no benefit for moderate lung disease
18 May, 2017 | 17:51h | UTCLong-term oxygen therapy shows no benefit for moderate lung disease – NIHR Signal: Dissemination Centre Discover Portal (free)
Original article: A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation – New England Journal of Medicine (free)
Patients with stable COPD and moderate resting desaturation (Spo2, 89 to 93%) or moderate exercise-induced desaturation (during the 6-minute walk test, Spo2 ≥80% for ≥5 minutes and <90% for ≥10 seconds) don’t seem to benefit from supplemental oxygen therapy.